BioSurplus Appoints Theresa Matkovits, Ph.D. to its Board of Directors

By January 24, 2017Media Placements

Theresa Matkovits, Ph.D., ContraVir’s Senior Vice President, Drug Development, has been appointed to the Board of Directors at BioSurplus, America’s preeminent buyer and reseller of preowned lab equipment. Her appointment to the BioSurplus board follows her recent participation in Women in Bio’s first Boardroom Ready Class.

“The knowledge that Dr. Matkovits brings to our board will be incredibly valuable as we continue to expand our offerings to life science companies and universities,” said Bill VanDeWeghe, President and Chief Executive Officer of BioSurplus. “Our new board members bring a sophisticated level of industry knowledge and experience that will help us better serve our customers.”

Read the Announcement